Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "Efficacy & Safety From MANTRA Study - Milademetan vs. Trabectedin in Patients With Dedifferentiated Liposarcomas"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Robin Jones
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Robin Jones
Login to view comments.
Click here to Login
